Search Results

World Renowned Childhood Blood Cancer Expert Named as The Leukemia & Lymphoma Society's New President and CEO

The Leukemia & Lymphoma Society (LLS), the global leader and innovator in creating a world without blood cancer, is proud to announce E. Anders Kolb, …

BURLINGTON STORES AND THE LEUKEMIA & LYMPHOMA SOCIETY CONTINUE THEIR PARTNERSHIP IN THE FIGHT AGAINST BLOOD CANCER

October , – Starting today through November , , Burlington Stores is encouraging customers to donate at checkout in their more than stores nationwid…

The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member

The Leukemia & Lymphoma Society (LLS) Announces Board of Directors Officer Appointments; Welcomes New Board Member

FDA Approves New Targeted Treatment for Acute Myeloid Leukemia

Rye Brook, N.Y., July , – The U.S. Food and Drug Administration (FDA) last week approved quizartinib (Vanflyta®) in combination with standard chemoth…

Chronic Myeloid Leukemia: Diagnosis, Treatment, and Side Effect Management

Chronic Lymphocytic Leukemia: Diagnosis, Treatment, and Side Effect Management

Chronic Lymphocytic Leukemia (CLL): What Are My Treatment Options?

The Leukemia & Lymphoma Society Announces Reimagined Executive Leadership Team

See full multimedia release here.

FDA Expands Use of Leukemia Treatment to Include Children

LLS supported the very first conjugate gemtuzumab ozogamicin, which targets CD33, and was approved in to treat acute myeloid leukemia.

Advancing the therapeutic landscape for Chronic Myelomonocytic Leukemia (CMML)

CMML is a universally lethal blood cancer characterized by increased monocytes (a type of white blood cell) in the peripheral blood and abnormal appea…

Charting the surfaceome to eliminate hairy cell leukemia (HCL)

To optimize treatment of HCL, we dissect the tumors` surface proteome to understand a) surface mediated signals and b) the dependence on BRAFV600E act…

LLS National Research Registry Progress Report - Chronic Lymphocytic Leukemia

LLS would like to thank all of the Chronic Lymphocytic Leukemia patients who contributed to the National Research Registry. Please see the report belo…

NRG Announces New Partnership with The Leukemia & Lymphoma Society

Los Angeles, CA - (September , ) - NRG announced The Leukemia & Lymphoma Society (LLS), the global leader in the fight to end blood cancer, as the tea…

Chronic Lymphocytic Leukemia (CLL): What Are My Treatment Options?

Please join The Leukemia & Lymphoma Society for a webcast for patients and caregivers. We invite you to learn more about: -Treatment options for CLL…

Chronic Lymphocytic Leukemia (CLL): What Are My Treatment Options?

Topics Covered We invite you to learn more about: Treatment options for CLL management Ways to effectively communicate with your healthcare tea…

Chronic myeloid leukemia (CML) in children and young adults

Most cases of CML occur in adults. From -, less than percent of all cases of CML occurred in children, adolescents, and young adults younger than .

The Leukemia & Lymphoma Society Expands Information Resource Center Hours

For Immediate ReleaseContact: Andrea GreifTel: () -8958Cell: () [email protected] ReleaseThe Leukemia & Lymphoma Society Expands Informati…

Leukemia & Lymphoma Society Board of Trustees, Southern Florida Chapter

Carolyn Cauceglia—Chair VP, Amadeus North America Inc. Vicky Garcia—Vice Chair COO & , Cruise Planners Michael Romagnolo—Vice Chair SVP, Sent…

Acute Lymphoblastic Leukemia: Diagnosis, Treatment and Side Effect Management

Click Here to ParticipateRecorded on: February , 2025Estimated Time to Complete: . hours2. CE Credits/Contact hours for nurses and social workers avai…

Acute Myeloid Leukemia: Diagnosis, Treatment and Side Effect Management

Click Here to ParticipateRecorded on: February , 2025Estimated Time to Complete: . hours1. CE Credits/Contact hours for nurses and social workers avai…

SUBARU SUPPORTS CANCER PATIENTS NATIONWIDE WITH RENEWED PARTNERSHIP WITH THE LEUKEMIA & LYMPHOMA SOCIETY®

Subaru of America, Inc. today announced that as part of its commitment to helping all people lead healthy lives, the automaker will partner with The L…

The Leukemia & Lymphoma Society's Response to the Israel-Hamas War

The following message was sent to all LLS employees on October , : Dear LLS Community,   As an organization, The Leukemia & Lymphoma Society (LLS) is …

Leukemia Patient’s Legacy Helps Drive Innovative Cancer Clinical Trial

Rye Brook, NY (March , ) - Turning sorrow into action, The Harry T. Mangurian Jr. Foundation, whose namesake died from acute myeloid leukemia (AML), c…

Magrolimab Demonstrates Clinical Responses in Ongoing Phase 1b Trial of Previously Untreated Acute Myeloid Leukemia Patients

December , - FOSTER CITY, Calif. - Gilead Sciences, Inc. (Nasdaq: GILD) today announced updated results from the magrolimab Phase 1b trial. Magrolima…

A phase 1/2 study of DR-01, an anti-CD94 monoclonal antibody, in patients with large granular lymphocytic leukemia or cytotoxic lymphomas

In November , LLS made an equity investment in Dren Bio to "Support Clinical Development of the Program for Rare Leukemia & Lymphoma Indications Incl…